Global Rabies Vaccine for Pets Market Research Report 2023

Publication ID:

PB504230211

Publication Date:

May 29, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Rabies vaccine refers to the vaccine used to prevent rabies. There are many effective and safe vaccines available. The rabies vaccine can be given either before or some time after exposure to the virus (such as a dog or bat bite).
The global Rabies Vaccine for Pets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Rabies Vaccine for Pets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Rabies Vaccine for Pets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Rabies Vaccine for Pets include Merck, Zoetis, Boehringer Ingelheim, Ceva, Virbac, Bavarian Nordic, Dyntec, Sanofi-Pasteur and Tianjin Ringpu Bio-Technology, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine for Pets.
The Rabies Vaccine for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Rabies Vaccine for Pets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rabies Vaccine for Pets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
Virbac
Bavarian Nordic
Dyntec
Sanofi-Pasteur
Tianjin Ringpu Bio-Technology
Segment by Type
Injectable Rabies Vaccine
Oral Rabies Vaccine
Segment by Application
Pet Hospital
Animal Epidemic Prevention Station
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rabies Vaccine for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rabies Vaccine for Pets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Rabies Vaccine for Pets Market Overview
1.1 Product Overview and Scope of Rabies Vaccine for Pets
1.2 Rabies Vaccine for Pets Segment by Type
1.2.1 Global Rabies Vaccine for Pets Market Value Comparison by Type (2023-2029)
1.2.2 Injectable Rabies Vaccine
1.2.3 Oral Rabies Vaccine
1.3 Rabies Vaccine for Pets Segment by Application
1.3.1 Global Rabies Vaccine for Pets Market Value by Application: (2023-2029)
1.3.2 Pet Hospital
1.3.3 Animal Epidemic Prevention Station
1.3.4 Others
1.4 Global Rabies Vaccine for Pets Market Size Estimates and Forecasts
1.4.1 Global Rabies Vaccine for Pets Revenue 2018-2029
1.4.2 Global Rabies Vaccine for Pets Sales 2018-2029
1.4.3 Global Rabies Vaccine for Pets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Rabies Vaccine for Pets Market Competition by Manufacturers
2.1 Global Rabies Vaccine for Pets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rabies Vaccine for Pets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rabies Vaccine for Pets Average Price by Manufacturers (2018-2023)
2.4 Global Rabies Vaccine for Pets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rabies Vaccine for Pets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rabies Vaccine for Pets, Product Type & Application
2.7 Rabies Vaccine for Pets Market Competitive Situation and Trends
2.7.1 Rabies Vaccine for Pets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rabies Vaccine for Pets Players Market Share by Revenue
2.7.3 Global Rabies Vaccine for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rabies Vaccine for Pets Retrospective Market Scenario by Region
3.1 Global Rabies Vaccine for Pets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rabies Vaccine for Pets Global Rabies Vaccine for Pets Sales by Region: 2018-2029
3.2.1 Global Rabies Vaccine for Pets Sales by Region: 2018-2023
3.2.2 Global Rabies Vaccine for Pets Sales by Region: 2024-2029
3.3 Global Rabies Vaccine for Pets Global Rabies Vaccine for Pets Revenue by Region: 2018-2029
3.3.1 Global Rabies Vaccine for Pets Revenue by Region: 2018-2023
3.3.2 Global Rabies Vaccine for Pets Revenue by Region: 2024-2029
3.4 North America Rabies Vaccine for Pets Market Facts & Figures by Country
3.4.1 North America Rabies Vaccine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rabies Vaccine for Pets Sales by Country (2018-2029)
3.4.3 North America Rabies Vaccine for Pets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rabies Vaccine for Pets Market Facts & Figures by Country
3.5.1 Europe Rabies Vaccine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rabies Vaccine for Pets Sales by Country (2018-2029)
3.5.3 Europe Rabies Vaccine for Pets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rabies Vaccine for Pets Market Facts & Figures by Country
3.6.1 Asia Pacific Rabies Vaccine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rabies Vaccine for Pets Sales by Country (2018-2029)
3.6.3 Asia Pacific Rabies Vaccine for Pets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rabies Vaccine for Pets Market Facts & Figures by Country
3.7.1 Latin America Rabies Vaccine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rabies Vaccine for Pets Sales by Country (2018-2029)
3.7.3 Latin America Rabies Vaccine for Pets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Rabies Vaccine for Pets Market Facts & Figures by Country
3.8.1 Middle East and Africa Rabies Vaccine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rabies Vaccine for Pets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rabies Vaccine for Pets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rabies Vaccine for Pets Sales by Type (2018-2029)
4.1.1 Global Rabies Vaccine for Pets Sales by Type (2018-2023)
4.1.2 Global Rabies Vaccine for Pets Sales by Type (2024-2029)
4.1.3 Global Rabies Vaccine for Pets Sales Market Share by Type (2018-2029)
4.2 Global Rabies Vaccine for Pets Revenue by Type (2018-2029)
4.2.1 Global Rabies Vaccine for Pets Revenue by Type (2018-2023)
4.2.2 Global Rabies Vaccine for Pets Revenue by Type (2024-2029)
4.2.3 Global Rabies Vaccine for Pets Revenue Market Share by Type (2018-2029)
4.3 Global Rabies Vaccine for Pets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Rabies Vaccine for Pets Sales by Application (2018-2029)
5.1.1 Global Rabies Vaccine for Pets Sales by Application (2018-2023)
5.1.2 Global Rabies Vaccine for Pets Sales by Application (2024-2029)
5.1.3 Global Rabies Vaccine for Pets Sales Market Share by Application (2018-2029)
5.2 Global Rabies Vaccine for Pets Revenue by Application (2018-2029)
5.2.1 Global Rabies Vaccine for Pets Revenue by Application (2018-2023)
5.2.2 Global Rabies Vaccine for Pets Revenue by Application (2024-2029)
5.2.3 Global Rabies Vaccine for Pets Revenue Market Share by Application (2018-2029)
5.3 Global Rabies Vaccine for Pets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Rabies Vaccine for Pets Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Zoetis Rabies Vaccine for Pets Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boehringer Ingelheim Rabies Vaccine for Pets Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ceva Rabies Vaccine for Pets Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Virbac Rabies Vaccine for Pets Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Bavarian Nordic
6.6.1 Bavarian Nordic Corporation Information
6.6.2 Bavarian Nordic Description and Business Overview
6.6.3 Bavarian Nordic Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bavarian Nordic Rabies Vaccine for Pets Product Portfolio
6.6.5 Bavarian Nordic Recent Developments/Updates
6.7 Dyntec
6.6.1 Dyntec Corporation Information
6.6.2 Dyntec Description and Business Overview
6.6.3 Dyntec Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dyntec Rabies Vaccine for Pets Product Portfolio
6.7.5 Dyntec Recent Developments/Updates
6.8 Sanofi-Pasteur
6.8.1 Sanofi-Pasteur Corporation Information
6.8.2 Sanofi-Pasteur Description and Business Overview
6.8.3 Sanofi-Pasteur Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sanofi-Pasteur Rabies Vaccine for Pets Product Portfolio
6.8.5 Sanofi-Pasteur Recent Developments/Updates
6.9 Tianjin Ringpu Bio-Technology
6.9.1 Tianjin Ringpu Bio-Technology Corporation Information
6.9.2 Tianjin Ringpu Bio-Technology Description and Business Overview
6.9.3 Tianjin Ringpu Bio-Technology Rabies Vaccine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Tianjin Ringpu Bio-Technology Rabies Vaccine for Pets Product Portfolio
6.9.5 Tianjin Ringpu Bio-Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rabies Vaccine for Pets Industry Chain Analysis
7.2 Rabies Vaccine for Pets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rabies Vaccine for Pets Production Mode & Process
7.4 Rabies Vaccine for Pets Sales and Marketing
7.4.1 Rabies Vaccine for Pets Sales Channels
7.4.2 Rabies Vaccine for Pets Distributors
7.5 Rabies Vaccine for Pets Customers
8 Rabies Vaccine for Pets Market Dynamics
8.1 Rabies Vaccine for Pets Industry Trends
8.2 Rabies Vaccine for Pets Market Drivers
8.3 Rabies Vaccine for Pets Market Challenges
8.4 Rabies Vaccine for Pets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Merck
Zoetis
Boehringer Ingelheim
Ceva
Virbac
Bavarian Nordic
Dyntec
Sanofi-Pasteur
Tianjin Ringpu Bio-Technology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂